
Lonza Delivers Strong Profitable Growth in Full-Year 2025 and Successfully Completes Vacaville Site Integration
In 2025, Lonza1 delivered sales of CHF 6.5 billion with +21.7% CER2 growth, and a CORE

In 2025, Lonza1 delivered sales of CHF 6.5 billion with +21.7% CER2 growth, and a CORE

Tokyo – January 27, 2026 – Asahi Kasei, Mitsui Chemicals, and Mitsubishi Chemical have

· Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America · Offers

Brussels, 28 January 2026 – A new report shows that chemical plant closures in Europe, has

The National Institutes of Health (NIH) today announced a new policy ending the use

Exposing vulnerabilities in traditional supply chain models In the last decade, increased protectionist

Introduction Every pharmaceutical contract development and manufacturing organization (CDMO) knows that quality is essential.
Home Panel Discussion On Panel Discussion on Biotech-CDMO Collaboration Panel Discussion on Biotech-CDMO Collaboration